Clinical Trials · NCT00590343
Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Louisiana State University Health Sciences Center in New Orleans
- Enrollment
- 23
- Start date
- Nov 2004
- Locations
- 1 site, United States
- Primary endpoint
- Change in biochemical markers.